BUZZ — Dr. Reddy's rises on India distribution deal for Takeda's dengue vaccine

* Shares of India's Dr. Reddy's rise as much as 2.76% to 1,207.50 rupees * REDY's signed an agreement with Japanese drugmaker Takeda Pharmaceutical to promote and distribute the Qdenga dengue vaccine in India * India's drug regulator approved Qdenga for use in both children and adults, making it the first dengue vaccine cleared for the country * Dr Reddy's said Qdenga, a two-dose dengue vaccine administered three months apart without the need for pre-vaccination screening, is expected to be available in India in the first half of 2027 * Thirty-six analysts have a "Hold" rating on avg; median PT is 1,221 rupees - data compiled * YTD, REDY down 4.2% (Reporting by Urvi Dugar in Bengaluru) ((mailto:UrviManoj.Dugar@thomsonreuters.com; +91 9558725583; )